TMDX Filing
4Filing Date: Mar 4, 2026

TransMedics Group, Inc. (TMDX) · Insider Trading (Form 4) SEC Filing

Statement of Changes in Beneficial Ownership

descriptionView SEC Filing
ACC: 0001193125-26-092241open_in_new
Total Value$1.63M
Trades7
Insiders1

Transaction Details

Hernandez Gerardo
Chief Financial Officer·Direct
Exercise · Dispose
Stock Option (Right to Buy)Derivative
Shares-5.91K
Price$0.00
Total Value$0
Shares Owned After13.01K
Transaction DateMar 4, 2026
ExpiresDec 9, 2034
Footnotes ▸

The option vested as to 25% of the shares underlying the option on December 2, 2025 and will continue to vest as to the remaining shares in equal monthly installments over three years thereafter, subject to continued service.

Hernandez Gerardo
Chief Financial Officer·Direct
Sell · Dispose
Common Stock
Shares-1.32K
Price$147.21
Total Value$194.9K
Shares Owned After14.69K
Transaction DateMar 4, 2026
Footnotes ▸

The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $147.14 to $147.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

Hernandez Gerardo
Chief Financial Officer·Direct
Exercise · Acquire
Common Stock
Shares+5.91K
Price$69.84
Total Value$412.9K
Shares Owned After20.60K
Transaction DateMar 4, 2026
Hernandez Gerardo
Chief Financial Officer·Direct
Sell · Dispose
Common Stock
Shares-5.91K
Price$147.21
Total Value$870.3K
Shares Owned After14.69K
Transaction DateMar 4, 2026
Footnotes ▸

The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $147.14 to $147.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

Hernandez Gerardo
Chief Financial Officer·Direct
Exercise · Dispose
Stock Option (Right to Buy)Derivative
Shares-1.32K
Price$0.00
Total Value$0
Shares Owned After3.98K
Transaction DateMar 4, 2026
ExpiresFeb 24, 2035
Footnotes ▸

The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following February 24, 2025 until the option is fully vested on February 24, 2029, subject to continued service.

Hernandez Gerardo
Chief Financial Officer·Direct
Exercise · Acquire
Common Stock
Shares+1.32K
Price$77.12
Total Value$102.1K
Shares Owned After16.01K
Transaction DateMar 4, 2026
Hernandez Gerardo
Chief Financial Officer·Direct
Sell · Dispose
Common Stock
Shares-375
Price$139.12
Total Value$52.2K
Shares Owned After14.69K
Transaction DateMar 2, 2026
Footnotes ▸

Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction pursuant to the terms of the RSU award.

Post-Transaction Holdings

Hernandez Gerardo
SecuritySharesChange
Common Stock14.69K-375 (-2.49%)
Stock Option (Right to Buy)13.01K-7.24K (-35.74%)
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-03-02 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: TransMedics Group, Inc. (TMDX) CIK: 0001756262 --- Reporting Owner --- Name: Hernandez Gerardo CIK: 0002046180 Role: Officer (Chief Financial Officer) --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-03-02 | Code: S (Open market sale) Shares: -375 | Price: $139.12 Total Value: $52,170.00 Shares Owned After: 14,689 | Ownership: D (Direct) Footnotes: [F1] Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction pursuant to the terms of the RSU award. [Transaction #2] Security: Common Stock Date: 2026-03-04 | Code: M (Exercise of derivative) Shares: +1,324 | Price: $77.12 Total Value: $102,106.88 Shares Owned After: 16,013 | Ownership: D (Direct) [Transaction #3] Security: Common Stock Date: 2026-03-04 | Code: S (Open market sale) Shares: -1,324 | Price: $147.21 Total Value: $194,906.04 Shares Owned After: 14,689 | Ownership: D (Direct) Footnotes: [F2] The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $147.14 to $147.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. [Transaction #4] Security: Common Stock Date: 2026-03-04 | Code: M (Exercise of derivative) Shares: +5,912 | Price: $69.84 Total Value: $412,894.08 Shares Owned After: 20,601 | Ownership: D (Direct) [Transaction #5] Security: Common Stock Date: 2026-03-04 | Code: S (Open market sale) Shares: -5,912 | Price: $147.21 Total Value: $870,305.52 Shares Owned After: 14,689 | Ownership: D (Direct) Footnotes: [F2] The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $147.14 to $147.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. --- Derivative Transactions --- [Transaction #1] Security: Stock Option (Right to Buy) Date: 2026-03-04 | Code: M (Exercise of derivative) Shares: -1,324 | Price: $0.00 Exercisable: N/A | Expires: 2035-02-24 Shares Owned After: 3,975 | Ownership: D (Direct) Footnotes: [F3] The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following February 24, 2025 until the option is fully vested on February 24, 2029, subject to continued service. [Transaction #2] Security: Stock Option (Right to Buy) Date: 2026-03-04 | Code: M (Exercise of derivative) Shares: -5,912 | Price: $0.00 Exercisable: N/A | Expires: 2034-12-09 Shares Owned After: 13,010 | Ownership: D (Direct) Footnotes: [F4] The option vested as to 25% of the shares underlying the option on December 2, 2025 and will continue to vest as to the remaining shares in equal monthly installments over three years thereafter, subject to continued service. --- Footnotes (Complete Index) --- F1: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction pursuant to the terms of the RSU award. F2: The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $147.14 to $147.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. F3: The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following February 24, 2025 until the option is fully vested on February 24, 2029, subject to continued service. F4: The option vested as to 25% of the shares underlying the option on December 2, 2025 and will continue to vest as to the remaining shares in equal monthly installments over three years thereafter, subject to continued service. --- Signature --- /s/ By: /s/ Gerardo Hernandez (2026-03-04)

keid analysis is for reference only and does not constitute investment advice.